Cargando…

Voting behavior during FDA Medical Device Advisory Committee panel meetings

OBJECTIVES: During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Maisel-Campbell, Amanda, Schlessinger, Daniel I., Yanes, Arianna F., Veledar, Emir, Reynolds, Kelly A., Ibrahim, Sarah A., Kang, Bianca Y., Anvery, Noor, Poon, Emily, Alam, Murad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231736/
https://www.ncbi.nlm.nih.gov/pubmed/35749461
http://dx.doi.org/10.1371/journal.pone.0267134
_version_ 1784735410982748160
author Maisel-Campbell, Amanda
Schlessinger, Daniel I.
Yanes, Arianna F.
Veledar, Emir
Reynolds, Kelly A.
Ibrahim, Sarah A.
Kang, Bianca Y.
Anvery, Noor
Poon, Emily
Alam, Murad
author_facet Maisel-Campbell, Amanda
Schlessinger, Daniel I.
Yanes, Arianna F.
Veledar, Emir
Reynolds, Kelly A.
Ibrahim, Sarah A.
Kang, Bianca Y.
Anvery, Noor
Poon, Emily
Alam, Murad
author_sort Maisel-Campbell, Amanda
collection PubMed
description OBJECTIVES: During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between individual votes and Panel recommendations and: (1) the composition of Panels, specifically the expertise and demographic features of individual members; or (2) Panel members’ propensity to speak during Panel deliberations. METHODS: This was a retrospective cohort study of routinely collected data from voting members of MDAC panels convened between January 2011 to June 2016 to consider premarket approval. Data sources were verbatim transcripts available publicly from the FDA. Number of words spoken, directionality of votes on device approval, profession, and demographics were collected. RESULTS: 658,954 words spoken by 536 members during 49 meetings of 11 Panels were analyzed. Based on multivariate analysis, biostatisticians spoke more (+373 words; P = 0.0002), and women (-187 words; P = 0.0184) and other non-physician voting members less (-213 words; P = 0.0306), than physicians. Speaking more was associated with abstaining (P = 0.0179), and with voting against the majority (P = 0.0153). Non-physician, non-biostatistician members (P = 0.0109), and those having attended more meetings as a voting member (P = 0.0249) were more likely to vote against approval. In bivariable analysis, unanimous Panels had a greater proportion of biostatisticians (mean 0.1580; 95% CI 0.1237–0.1923) than non-unanimous Panels (0.1107; 95% CI 0.0912–0.1301; p = 0.0201). CONCLUSIONS: Panelists likely to vote against the majority include non-physician, non-biostatisticians; experienced Panelists; and more talkative members. The increased presence of biostatisticians on Panels leads to greater voting consensus. Having a diversity of opinions on Panels, including in sufficient numbers those members likely to dissent from majority views, may help ensure that a diversity of opinions are aired before decision-making.
format Online
Article
Text
id pubmed-9231736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-92317362022-06-25 Voting behavior during FDA Medical Device Advisory Committee panel meetings Maisel-Campbell, Amanda Schlessinger, Daniel I. Yanes, Arianna F. Veledar, Emir Reynolds, Kelly A. Ibrahim, Sarah A. Kang, Bianca Y. Anvery, Noor Poon, Emily Alam, Murad PLoS One Research Article OBJECTIVES: During premarket review, the US Food and Drug Administration may ask its Medical Device Advisory Committee (MDAC) Panels to assess the safety and effectiveness of medical devices being considered for approval. The objective of this study is to assess the relationship, if any, between individual votes and Panel recommendations and: (1) the composition of Panels, specifically the expertise and demographic features of individual members; or (2) Panel members’ propensity to speak during Panel deliberations. METHODS: This was a retrospective cohort study of routinely collected data from voting members of MDAC panels convened between January 2011 to June 2016 to consider premarket approval. Data sources were verbatim transcripts available publicly from the FDA. Number of words spoken, directionality of votes on device approval, profession, and demographics were collected. RESULTS: 658,954 words spoken by 536 members during 49 meetings of 11 Panels were analyzed. Based on multivariate analysis, biostatisticians spoke more (+373 words; P = 0.0002), and women (-187 words; P = 0.0184) and other non-physician voting members less (-213 words; P = 0.0306), than physicians. Speaking more was associated with abstaining (P = 0.0179), and with voting against the majority (P = 0.0153). Non-physician, non-biostatistician members (P = 0.0109), and those having attended more meetings as a voting member (P = 0.0249) were more likely to vote against approval. In bivariable analysis, unanimous Panels had a greater proportion of biostatisticians (mean 0.1580; 95% CI 0.1237–0.1923) than non-unanimous Panels (0.1107; 95% CI 0.0912–0.1301; p = 0.0201). CONCLUSIONS: Panelists likely to vote against the majority include non-physician, non-biostatisticians; experienced Panelists; and more talkative members. The increased presence of biostatisticians on Panels leads to greater voting consensus. Having a diversity of opinions on Panels, including in sufficient numbers those members likely to dissent from majority views, may help ensure that a diversity of opinions are aired before decision-making. Public Library of Science 2022-06-24 /pmc/articles/PMC9231736/ /pubmed/35749461 http://dx.doi.org/10.1371/journal.pone.0267134 Text en © 2022 Maisel-Campbell et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Maisel-Campbell, Amanda
Schlessinger, Daniel I.
Yanes, Arianna F.
Veledar, Emir
Reynolds, Kelly A.
Ibrahim, Sarah A.
Kang, Bianca Y.
Anvery, Noor
Poon, Emily
Alam, Murad
Voting behavior during FDA Medical Device Advisory Committee panel meetings
title Voting behavior during FDA Medical Device Advisory Committee panel meetings
title_full Voting behavior during FDA Medical Device Advisory Committee panel meetings
title_fullStr Voting behavior during FDA Medical Device Advisory Committee panel meetings
title_full_unstemmed Voting behavior during FDA Medical Device Advisory Committee panel meetings
title_short Voting behavior during FDA Medical Device Advisory Committee panel meetings
title_sort voting behavior during fda medical device advisory committee panel meetings
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231736/
https://www.ncbi.nlm.nih.gov/pubmed/35749461
http://dx.doi.org/10.1371/journal.pone.0267134
work_keys_str_mv AT maiselcampbellamanda votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT schlessingerdanieli votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT yanesariannaf votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT veledaremir votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT reynoldskellya votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT ibrahimsaraha votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT kangbiancay votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT anverynoor votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT poonemily votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings
AT alammurad votingbehaviorduringfdamedicaldeviceadvisorycommitteepanelmeetings